Latest news releases from NIH-funded organizations
Funded Research News
Updates every hour. Last Updated: 23-Dec-2025 22:11 ET (24-Dec-2025 03:11 GMT/UTC)
Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide
Technical University of Munich (TUM)Peer-Reviewed Publication
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School have demonstrated this in using insurance claims data. They found that semaglutide and tirzepatide – marketed as Ozempic and Mounjaro – reduced the risk of serious cardiovascular events by up to 18 percent.
- Journal
- Nature Medicine
- Funder
- NIH/National Institutes of Health, Deutsche Herzstiftung
- Meeting
- American Heart Association Scientific Sessions 2025
GLP-1 drugs tirzepatide and semaglutide provide protection for heart health
Mass General BrighamPeer-Reviewed Publication
- Journal
- Nature Medicine
- Funder
- NIH/National Institutes of Health, NIH/National Institutes of Health, German Heart Foundation
Breast cancer case study could inform clinical trials
Cold Spring Harbor LaboratoryPeer-Reviewed Publication
CSHL Professor David Spector and graduate student Disha Aggarwal have tracked levels of long non-coding RNA MALAT1 over the course of one woman’s experience with triple-negative breast cancer. Their findings could help inform clinical trials of a drug targeting MALAT1. They also suggest MALAT1 may play a role in determining whether and where the cancer will spread.
- Journal
- Molecular Therapy Oncology
- Funder
- NIH/National Institutes of Health, NIH/National Cancer Institute, Cold Spring Harbor Laboratory, Northwell Health
Should kids be screened for high cholesterol genes?
Columbia University Irving Medical CenterPeer-Reviewed Publication
- Journal
- JAMA
- Funder
- NIH/National Institutes of Health